Development of a Simple Noninvasive Model to Predict Significant Fibrosis in Patients with Chronic Hepatitis B: Combination of Ultrasound Elastography, Serum Biomarkers, and Individual Characteristics

被引:12
|
作者
Chen, Xin [1 ,2 ]
Wen, Huiying [1 ,2 ]
Zhang, Xinyu [1 ,2 ]
Dong, Changfeng [3 ]
Lin, Haoming [1 ,2 ]
Guo, Yanrong [1 ,2 ]
Shan, Lingbo [3 ]
Yao, Simin [3 ]
Yang, Min [3 ]
Le, Xiaohua [2 ]
Liu, Yingxia [3 ]
机构
[1] Shenzhen Univ, Sch Biomed Engn, Shenzhen, Peoples R China
[2] Guangdong Key Lab Biomed Measurements & Ultrasoun, Natl Reg Key Technol Engn Lab Med Ultrasound, Shenzhen, Peoples R China
[3] Shenzhen Third Peoples Hosp, Shenzhen Inst Hepatol, Shenzhen 518020, Peoples R China
基金
中国国家自然科学基金;
关键词
RADIATION FORCE IMPULSE; LIVER FIBROSIS; TRANSIENT ELASTOGRAPHY; INDEX; BIOPSY; ALGORITHMS; ARFI; QUANTIFICATION; REPEATABILITY; MARKERS;
D O I
10.1038/ctg.2017.11
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
OBJECTIVES: The accurate assessment of liver fibrosis is clinically important in patients with chronic hepatitis B (CHB). Blood tests and elastography are now widely used for the noninvasive diagnosis of liver fibrosis in CHB patients. The aim of this study was to develop a new and more accurate predictive model, which combines elastography data, serum biomarkers, and individual characteristics, to discriminate between CHB patients with and without significant liver fibrosis. METHODS: Two noninvasive methods, specifically, an ultrasound elastography technique termed acoustic radiation force impulse imaging (ARFI) and a blood test, were used to assess a cohort of 345 patients (estimation group, 218 patients; validation group, 127 patients) with CHB. Multivariate logistic regression analysis revealed that ARFI, the aspartate aminotransferase (AST) to platelet ratio, and age were significantly associated with fibrosis. Based on these results, we constructed and validated a model for the diagnosis of significant hepatic fibrosis. RESULTS: The area under the receiver operating characteristic (ROC) curve was 0.921 for the estimation group and 0.929 for the validation group, significantly higher than those for ARFI (0.887, 0.893) and for the AST-to-platelet ratio index (APRI; 0.811, 0.859). Using an optimal cutoff of 3.05 in the validation group, all the indices of the proposed model, including accuracy, sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic odds ratio, were better than those for ARFI or APRI. CONCLUSIONS: We developed a simple noninvasive model that used ultrasound elastography, routine serum biomarkers, and individual characteristics to accurately differentiate significant fibrosis in patients with CHB. Compared with elastography or the biomarker index alone, this model was significantly more accurate and robust.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] A simple noninvasive model to predict significant fibrosis in children with chronic hepatitis B
    Zhang, Kang-Ling
    Chen, Xiu-Qi
    Lv, Zi-Li
    Tang, Qing
    Shan, Qing-Wen
    [J]. MEDICINE, 2021, 100 (25) : E26462
  • [2] Establishment and validation of a simple noninvasive model to predict significant liver fibrosis in patients with chronic hepatitis B
    Sheng-di Wu
    Yan-jun Ni
    Li–li Liu
    Hai Li
    Lun-gen Lu
    Ji-Yao Wang
    [J]. Hepatology International, 2012, 6 : 360 - 368
  • [3] Establishment and validation of a simple noninvasive model to predict significant liver fibrosis in patients with chronic hepatitis B
    Wu, Sheng-di
    Ni, Yan-jun
    Liu, Li-li
    Li, Hai
    Lu, Lun-gen
    Wang, Ji-Yao
    [J]. HEPATOLOGY INTERNATIONAL, 2012, 6 (01) : 360 - 368
  • [4] Identification of chronic hepatitis B patients without significant liver fibrosis by a simple noninvasive predictive model
    Hui, AY
    Chan, HLY
    Wong, VWS
    Liew, CT
    Chim, AML
    Chan, FKL
    Sung, JJY
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (03): : 616 - 623
  • [5] Utility of Transient Elastography and Serum Markers of Fibrosis to Predict Significant and Advanced Fibrosis in Patients with Chronic Hepatitis C
    Samea, Eman Abdel
    Abdel-Razek, Wael
    Ehsan, Nermine
    Salama, Mohsen
    Waked, Imam
    [J]. HEPATOLOGY, 2013, 58 : 603A - 603A
  • [6] A NONINVASIVE MODEL FOR PREDICTING SIGNIFICANT FIBROSIS IN CHRONIC HEPATITIS B
    Seo, Yeon Seok
    Lee, Kwang Gyun
    Jung, Eun Suk
    Kim, Ji Hoon
    An, Hyonggin
    Keum, Bora
    Yim, Hyung Joon
    Jeen, Yoon Tae
    Yeon, Jong Eun
    Chun, Hoon Jai
    Byun, Kwan Soo
    Um, Soon Ho
    Kim, Chang Duck
    Ryu, Ho Sang
    [J]. HEPATOLOGY, 2009, 50 (04) : 981A - 981A
  • [7] Comparison of serum fibrosis biomarkers for diagnosing significant liver fibrosis in patients with chronic hepatitis B
    Tsuji, Yuki
    Namisaki, Tadashi
    Kaji, Kosuke
    Takaya, Hiroaki
    Nakanishi, Keisuke
    Sato, Shinya
    Saikawa, Soichiro
    Sawada, Yasuhiko
    Kitagawa, Kou
    Shimozato, Naotaka
    Kawaratani, Hideto
    Moriya, Kei
    Noguchi, Ryuichi
    Akahane, Takemi
    Mitoro, Akira
    Yoshiji, Hitoshi
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2020, 20 (02) : 985 - 995
  • [8] A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C
    Wai, CT
    Greenson, JK
    Fontana, RJ
    Kalbfleisch, JD
    Marrero, JA
    Conjeevaram, HS
    Lok, ASF
    [J]. HEPATOLOGY, 2003, 38 (02) : 518 - 526
  • [9] Serum Biomarkers Predictive of Significant Fibrosis and Cirrhosis in Chronic Hepatitis B
    Lin, Chih-Lin
    Liu, Chen-Hua
    Wang, Chia-Chi
    Liang, Cheng-Chao
    Su, Tung-Hung
    Liu, Chun-Jen
    Kao, Jia-Horng
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2015, 49 (08) : 705 - 713
  • [10] SHFI: A Novel Noninvasive Predictive Model for Significant Fibrosis in Patients With Chronic Hepatitis B
    Arslan, Fatma Demet
    Karakoyun, Inanc
    Tatar, Bengu
    Pala, Emel Ebru
    Yildirim, Mustafa
    Ulasoglu, Celal
    Duman, Can
    Akar, Harun
    Kose, Sukran
    Basok, Banu Isbilen
    [J]. HEPATITIS MONTHLY, 2018, 18 (02)